DSIP

DSIP (Delta Sleep-Inducing Peptide) is a neuropeptide first isolated from cerebral venous blood of rabbits in 1974 by Marcel Monnier and colleagues at the University of Basel. The nonapeptide, composed of nine amino acids, was named for its initial observation of delta EEG wave induction in research subjects, an electrophysiological pattern associated with deep sleep stages.

In the decades since its discovery, DSIP has been studied across a broader range of research domains beyond sleep physiology. Investigators have examined its interactions with the hypothalamic-pituitary-adrenal (HPA) axis, stress response systems, and neuroendocrine signaling, as well as its apparent ability to cross the blood-brain barrier under certain experimental conditions.

DSIP exhibits an unusual property among neuropeptides in that it appears relatively stable in plasma despite its small size, a characteristic researchers have attributed to possible circulating binding proteins. This pharmacokinetic profile has made it a subject of investigation in neuroendocrinology, sleep research, and stress physiology at the laboratory level.

DSIP (Delta Sleep-Inducing Peptide) is in stock and available to buy online from Optimum ReGen Peptides — a real American research-peptide company with a physical storefront in Medford, Oregon, not an anonymous overseas dropshipper. Priced from $35, every order ships within two business days, flat $12.50 nationwide, in plain discreet packaging with tracking.

As your DSIP supplier we back every batch with a third-party certificate of analysis and compound in a licensed US 503A pharmacy. Vials are supplied lyophilized at analytical purity for laboratory and research use only, not for human consumption.

Classical DSIP research employs EEG telemetry in freely moving rodents or rabbits, with continuous electrophysiological recording used to quantify changes in sleep architecture following peptide administration. Power spectral analysis of EEG frequency bands allows researchers to objectively characterize delta, theta, and spindle activity in treated versus control animals.

HPA axis studies measure serum cortisol, ACTH, and CRH levels via radioimmunoassay or ELISA following DSIP administration in stress-challenged animal models. Researchers examine dose-response relationships and time-course effects to characterize how the peptide interacts with the stress hormone cascade under controlled laboratory conditions.

Neuroendocrine experiments use pituitary cell cultures (GH3, AtT-20) and primary pituitary tissue explants to measure peptide release in response to DSIP. Mass spectrometry-based peptide profiling and protein expression panels help researchers map DSIP's interactions with hormone-secreting cell populations at the molecular level.